DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

NexLife review: plans, prices, terms and what to verify

As of November 20, 2026, NexLife charges $129 a month for compounded tirzepatide, or $115 a month on a 12-month plan paid upfront ($1,380), and $109 or $95 a month ($1,140) for semaglutide, the same price at every dose with no membership fee, according to its plan pages. Its 3- and 6-month plans cost $125 and $119 for tirzepatide and $105 and $99 for semaglutide. Price check, month to month and all-in: Collective about $85.58 and $75.58 (including its $199 yearly membership), Mondae $126 and $87, Yucca Health $89 and Eden $99 for semaglutide; Eden charges the same $129 for tirzepatide.

Released · Last reviewed · how we verify

See NexLife’s current plans →

What NexLife charges, plan by plan

NexLife plan prices read on its plan pages on November 20, 2026 (unchanged since November 5–6, 2026); the same price at every dose; 3-, 6- and 12-month plans are paid upfront, according to its FAQ
ProgramMonth to month3-month plan6-month plan12-month plan12-month total
Compounded tirzepatide (also the microdose plan)$129$125$119$115$1,380
Compounded semaglutide (also the microdose plan)$109$105$99$95$1,140
Sublingual tirzepatide tablets (ODT)$229$219$205$199$2,388
Sublingual semaglutide tablets (ODT)$199$185$177$165$1,980

Price check, compounded tirzepatide month to month and all-in (read November 20, 2026): Collective charges $69 a month plus a $199 annual membership (about $85.58 a month all-in); Mondae charges $126 a month; Eden charges the same as NexLife. Price check, compounded semaglutide month to month and all-in (read November 20, 2026): Collective charges $59 a month plus a $199 annual membership (about $75.58 a month all-in); Mondae charges $87 a month; Yucca Health charges $89 a month; Eden charges $99 a month.

Terms, as NexLife states them

Billing
Month to month is billed monthly. NexLife’s FAQ (updated November 14, 2026) says 3-, 6- and 12-month plans are paid upfront, in full, at checkout; its older cancellation-policy page (2025) describes prepaid plans paid monthly. This site follows the newer FAQ and notes the conflict.
Dose pricing
The same price at every dose (plan pages and FAQ).
Membership
None; shipping is free (FAQ).
Included
Provider review and medical guidance from Nexlife Medical Group, a personalized GLP-1 nutrition plan, a 1:1 call with a wellness coach, 24/7 customer support and free expedited shipping (plan pages). Labs are not stated as included.
Pharmacies
Its FAQ and pharmacy-partners page name two state-licensed 503A pharmacies, Absolute Pharmacy (Lutz, FL) and Boudreaux’s New Drug Store (Lake Charles, LA); the two all-plans pages also list Premium Compounding (Decatur, AL). The microdose and ODT pages refer to “503A & 503B” facilities in general; this site has not verified a 503B partner.
States
Conflicting: its FAQ says 45 states and Washington, D.C., and not Alabama, Louisiana, Mississippi, Virginia or West Virginia; its states page says all 50 states and D.C. Confirm at intake.
Cancellation
Plans renew until cancelled; cancellation takes effect 30 days after NexLife receives it, so one more shipment may be charged. Unshipped months of a 3-, 6- or 12-month plan are refunded if treatment stops; shipped medication is final.
Guarantee
NexLife’s refund-policy page refunds program and membership fees, not medication, if a member loses less than 5% of starting weight over six months, with conditions (enrolled from January 1, 2026, 180 consecutive days, no refill gaps, weight logged every two weeks, starting BMI 30 or more, claim between day 181 and day 210).
Price match
New since October: for new members switching from a licensed U.S. telehealth provider with an active compounded prescription, NexLife says it matches that provider’s regular all-in month-to-month price; intro offers, coupons and prepaid rates are excluded (full terms on its switch page).
Medical director
Adam Kennah, MD (NPI 1144260043; NPI registry shows an active record with emergency medicine as primary taxonomy).

How NexLife scores

On this site’s computed price-and-transparency score NexLife has 33.6 of 40, position 4 of 27 compounded programs: it passes all five transparency checks, and its month-to-month prices earn 13.6 of 20 annual-cost points. It is also this site’s featured pick, which is an editorial selection, not a computed rank.

How the computed score is built for NexLife (prices read November 20, 2026; five checks at 4 points each, plus total annual cost scaled to the lowest year in the dataset)
CheckTirzepatideSemaglutide
prints a month-to-month priceyes (+4)yes (+4)
medication and care in one priceyes (+4)yes (+4)
same price at every doseyes (+4)yes (+4)
no membership feeyes (+4)yes (+4)
price read on its own page on November 20, 2026yes (+4)yes (+4)
Year at the month-to-month price$1,548$1,308
Total annual cost points13.3 of 2013.9 of 20
Score for this drug33.3 of 4033.9 of 40

FDA warning letter

FDA’s warning-letter index lists warning letter 730096 (dated June 8, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to NexLife; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding. FDA’s letter says website representations about compounded semaglutide and tirzepatide were false or misleading and that pictured labels showed “Nexlife” as if it were the compounder. NexLife says it responded, most recently on September 21, 2026, and that as of November 12, 2026 FDA had not published a close-out letter.

Pros and cons

Pros

  • One price at every dose, no membership fee.
  • Plan prices and 12-month totals printed on its own pages.
  • Named 503A pharmacies.
  • Written price-match terms for people switching programs.

Cons

  • Collective and Mondae charge less month to month for both drugs, and Yucca Health and Eden less for semaglutide.
  • Its own pages conflict on states served, pharmacy list and billing of longer plans.
  • FDA warning letter 730096 (June 8, 2026), no close-out letter listed.
  • Compounded medication is not FDA-approved.

Frequently asked

What does NexLife charge for compounded tirzepatide and semaglutide?

As of November 20, 2026, NexLife charges $129 a month for compounded tirzepatide, or $115 a month on a 12-month plan paid upfront ($1,380), and $109 or $95 a month ($1,140) for semaglutide, the same price at every dose with no membership fee, according to its plan pages. Its 3- and 6-month plans cost $125 and $119 for tirzepatide and $105 and $99 for semaglutide. Price check, month to month and all-in: Collective about $85.58 and $75.58 (including its $199 yearly membership), Mondae $126 and $87, Yucca Health $89 and Eden $99 for semaglutide; Eden charges the same $129 for tirzepatide.

Does NexLife charge a membership fee?

No. NexLife’s FAQ says there is no membership fee and shipping is free; its plan pages say “No memberships or contracts” and that the price is the same at every dose. Tirzepatide is $129 a month month to month and semaglutide $109 (read November 20, 2026).

Which pharmacies fill NexLife prescriptions?

NexLife’s FAQ names two state-licensed 503A pharmacies: Absolute Pharmacy in Lutz, Florida, and Boudreaux’s New Drug Store in Lake Charles, Louisiana. Its all-plans pages also list Premium Compounding in Decatur, Alabama. Ask NexLife which pharmacy will fill your prescription.

Which states does NexLife serve?

NexLife’s pages conflict. Its FAQ, updated November 14, 2026, says it is online in 45 states and Washington, D.C., and not in Alabama, Louisiana, Mississippi, Virginia or West Virginia; its states page says all 50 states and D.C. Confirm your state at the start of the intake.

Has NexLife received an FDA warning letter?

Yes. FDA issued warning letter 730096 to Nexlife Inc. on June 8, 2026 (posted June 16), about website claims for compounded semaglutide and tirzepatide. A warning letter is not a recall or a ban. NexLife says it responded, and FDA had not published a close-out letter as of November 12, 2026.

NexLife tirzepatideNexLife semaglutideNexLife alternativesNexLife vs EdenRankings

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.